<Disease><Name>MAPLE SYRUP URINE DISEASE (MSUD)</Name><Synonym>BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY (MSUD)</Synonym><OMIM><Number>248600</Number><URL>http://omim.org/entry/248600</URL></OMIM><Orphanet><Number>511</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=511</URL></Orphanet><Protein><Number>Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial; 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial;2-oxoisovalerate dehydrogenase subunit beta, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/?query=database:(type:mim%20248600)&amp;sort=score</URL></Protein><ExPASy><Number>1.2.4.4</Number><URL>http://enzyme.expasy.org/EC/1.2.4.4</URL></ExPASy><Gene>1p21.2, 6q14.1, 19q13.2</Gene><ICD>E71.0</ICD><Summary>rare (1:200000 in Germany - 1:185000 world wide);autosomal recessive (homozygous or compound) ;4 different types: ;(1) classic form ;(2) intermittent form (normal between atacks) ;(3) intermediate form ;(4) Thiamine-responsive;(5) Dihydrolipoyl dehydrogenase (E3)-deficient ;mutation in at least 3 genes: BCKDHA, BCKDHB, DBT;In MS/MS newborn screening, the mass spectrum of hydroxyproline cannot be differentiated from isoleucine and leucine causing false positive newborn screening test results for maple syrup urine disease (MSUD) [Staufner et al. 2016]</Summary><Symptoms><symtomp><id>3210</id><symptom>apnea</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3782</id><symptom>behavior, anxiety</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2452</id><symptom>cerebral edema / brain edema</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>4107</id><symptom>Encephalopathic crisis, acute</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3916</id><symptom>episodic course (clinical symptoms)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3198</id><symptom>ketosis, ketoacidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2155</id><symptom>maple sirup or caramel odor / R09.3</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2339</id><symptom>ophthalmoplegia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2298</id><symptom>opisthotonus</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2210</id><symptom>pancreatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3974</id><symptom>papilloedema</symptom><category>EYES</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3997</id><symptom>screaming or crying, abnormal</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2250</id><symptom>skoliosis, kyphoskoliosis</symptom><category>BODY | SKELATAL DEFECT</category></symtomp><symtomp><id>2329</id><symptom>unusual odor / odour</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>2069</id><name>2-Hydroxy-3-methylvaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1648</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.40</min><max>2.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1649</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>5.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1657</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>7.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1728</id><name>2-Oxoisocaproic acid</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1729</id><name>2-Oxoisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1730</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>97.00</min><max>100.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1771</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>47.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1773</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>13.00</min><max>40.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1787</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>24.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1948</id><name>L-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>30.00</min><max>108.00</max><unit>&#956;mol/ml</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1949</id><name>L-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>30.00</min><max>105.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1950</id><name>L-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>34.00</min><max>106.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1951</id><name>Leucine</name><specimen>plasma</specimen><value>increased</value><min>61.00</min><max>162.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1952</id><name>Leucine</name><specimen>plasma</specimen><value>increased</value><min>59.00</min><max>180.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1953</id><name>Leucine</name><specimen>plasma</specimen><value>increased</value><min>86.00</min><max>206.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1972</id><name>Valine</name><specimen>plasma</specimen><value>increased</value><min>119.00</min><max>336.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1973</id><name>Valine</name><specimen>plasma</specimen><value>increased</value><min>155.00</min><max>343.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>2065</id><name>Valine</name><specimen>plasma</specimen><value>increased</value><min>99.00</min><max>286.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>2066</id><name>L-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>30.00</min><max>108.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1565</id><name>2-Hydroxy-3-methylvaleric acid</name><specimen>urine</specimen><value>increased</value><min>1.70</min><max>7.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>79</id><name>2-Hydroxy-3-methylvaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1326</id><name>2-Hydroxy-3-methylvaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>2001</id><name>2-Hydroxy-3-methylvaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>78</id><name>2-Hydroxyisocaproic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1323</id><name>2-Hydroxyisocaproic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>GCMS</method><comment /></metabolite><metabolite><id>1719</id><name>2-Hydroxyisocaproic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>37.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>2-Hydroxy-4-methylvaleric acid [+]</comment></metabolite><metabolite><id>77</id><name>2-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>352</id><name>2-Hydroxyisovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>18.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>353</id><name>2-Hydroxyisovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit /><age>adult</age><method /><comment /></metabolite><metabolite><id>1319</id><name>2-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1711</id><name>2-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>75</id><name>3-Methyl-2-oxovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>372</id><name>3-Methyl-2-oxovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>8.00</max><unit /><age>child</age><method /><comment /></metabolite><metabolite><id>373</id><name>3-Methyl-2-oxovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>8.00</min><max>31.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1360</id><name>3-Methyl-2-oxovaleric acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>7.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>74</id><name>2-Oxoisocaproic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>374</id><name>2-Oxoisocaproic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>9.50</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>375</id><name>2-Oxoisocaproic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>58.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1359</id><name>2-Oxoisocaproic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>GCMS</method><comment /></metabolite><metabolite><id>76</id><name>2-Oxoisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>368</id><name>2-Oxoisovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>369</id><name>2-Oxoisovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>28.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1863</id><name>2-Oxoisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.20</min><max>1.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>348</id><name>3-Hydroxybutyric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>280.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>349</id><name>3-Hydroxybutyric acid</name><specimen>plasma</specimen><value>increased</value><min>22.00</min><max>700.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>510</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>9.80</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>512</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>5.80</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>513</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>1.30</min><max>6.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>713</id><name>3-Hydroxybutyric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>20.00</min><max>60.00</max><unit>&#956;mol/l</unit><age /><method /><comment /></metabolite><metabolite><id>237</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.10</min><max>1.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>240</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.10</min><max>0.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>243</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.00</min><max>0.30</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>238</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.50</min><max>2.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>241</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.80</min><max>2.60</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>244</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.10</min><max>0.80</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>239</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>1.10</min><max>2.80</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>242</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>2.50</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>245</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.70</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>511</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>526</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>1726</id><name>3-Methyl-2-oxovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>3-Methyl-2-ketovaleric acid statt 2-Methyl-3-ketovaleric aci</comment></metabolite><metabolite><id>189</id><name>allo-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>190</id><name>allo-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1506</id><name>allo-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1501</id><name>allo-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1502</id><name>allo-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1503</id><name>allo-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>775</id><name>BCKAD complex</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1885</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1201</id><name>Ferric chloride reaction</name><specimen>urine</specimen><value /><min>    </min><max>    </max><unit>negative</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1413</id><name>D-Glucose</name><specimen>urine</specimen><value /><min>100.00</min><max>209.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment>day 1-7</comment></metabolite><metabolite><id>1609</id><name>D-Glucose</name><specimen>urine</specimen><value /><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1844</id><name>D-Glucose</name><specimen>urine</specimen><value /><min>76.00</min><max>810.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>47</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adolescence</age><method /><comment>fasted</comment></metabolite><metabolite><id>281</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment>fasted</comment></metabolite><metabolite><id>282</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>3.30</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment>fasted</comment></metabolite><metabolite><id>280</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>1.10</min><max>3.30</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>283</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>2.20</min><max>3.30</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, 1 day</comment></metabolite><metabolite><id>46</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>2.80</min><max>5.00</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, &gt;1 day</comment></metabolite><metabolite><id>399</id><name>D-Glucose</name><specimen>cerebrospinal fluid</specimen><value /><min>1.70</min><max>3.70</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1134</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>2.70</min><max>4.50</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1135</id><name>D-Glucose</name><specimen>plasma</specimen><value /><min>3.00</min><max>4.30</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>490</id><name>D-Glucose</name><specimen>blood</specimen><value /><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>333</id><name>D-Glucose</name><specimen>blood</specimen><value /><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>334</id><name>D-Glucose</name><specimen>blood</specimen><value /><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>154</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>868</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1508</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>50</id><name>L-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>23.00</min><max>102.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1207</id><name>L-Isoleucine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>11.70</max><unit>&#956;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1208</id><name>L-Isoleucine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.30</min><max>7.70</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1209</id><name>L-Isoleucine</name><specimen>plasma</specimen><value>increased</value><min>28.00</min><max>92.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>475</id><name>Ketone bodies (urine)</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>negative</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1913</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1914</id><name>L-Isoleucine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1915</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1925</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>13.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>767</id><name>L-Lactic acid</name><specimen>jejunal biopsy</specimen><value>increased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>21</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>3.50</min><max>29.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>536</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>197.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>537</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>40.00</min><max>326.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>538</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>5.00</min><max>117.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>539</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>6.00</min><max>64.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1411</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>100.00</min><max>152.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>330</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>3.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>339</id><name>L-Lactic acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.50</min><max>1.80</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>469</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>208</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>211</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>214</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>1.00</min><max>2.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>206</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.90</min><max>2.00</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>209</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.50</min><max>1.60</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>212</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.60</min><max>0.90</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>202</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>210</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>213</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.40</min><max>1.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1137</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.40</min><max>0.90</max><unit>mmol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>1136</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>1.60</max><unit>mmol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>203</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>204</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>1.00</min><max>1.50</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>207</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>2.00</min><max>3.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1813</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>45.00</min><max>410.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1481</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>470</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>869</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>18.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1509</id><name>Leucine</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>49</id><name>Leucine</name><specimen>plasma</specimen><value>increased</value><min>48.00</min><max>180.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1205</id><name>Leucine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>23.40</max><unit>&#956;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1206</id><name>Leucine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>3.30</min><max>21.20</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1210</id><name>Leucine</name><specimen>plasma</specimen><value>increased</value><min>47.00</min><max>155.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>793</id><name>pH</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>7.00</max><unit>no unit</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>60</id><name>pH</name><specimen>blood</specimen><value>normal/dec</value><min>7.35</min><max>7.45</max><unit>no unit</unit><age>child</age><method /><comment /></metabolite><metabolite><id>302</id><name>pH</name><specimen>blood</specimen><value>normal/dec</value><min>7.20</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>303</id><name>pH</name><specimen>blood</specimen><value>normal/dec</value><min>7.10</min><max>7.30</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>301</id><name>pH</name><specimen>blood</specimen><value>normal/dec</value><min>7.30</min><max>7.50</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>300</id><name>pH</name><specimen>blood</specimen><value>normal/dec</value><min>7.10</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>149</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1518</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1554</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>866</id><name>Valine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>21.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>48</id><name>Valine</name><specimen>plasma</specimen><value>increased</value><min>64.00</min><max>320.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1203</id><name>Valine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>44.00</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1204</id><name>Valine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>7.70</min><max>20.30</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1211</id><name>Valine</name><specimen>plasma</specimen><value>increased</value><min>64.00</min><max>294.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1280</id><name>Valine</name><specimen>blood</specimen><value>increased</value><min>51.98</min><max>195.68</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1281</id><name>Valine</name><specimen>plasma</specimen><value>increased</value><min>59.00</min><max>201.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>7449</id><title>Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department</title><author>Y&#305;ld&#305;z Y,</author><journal>Eur J Pediatr</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7450</id><title>[Hypoglycaemia and seizures in a 32-year-old woman with maple syrup urine disease]</title><author>Kraemer J,</author><journal>Internist (Berl)</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Kraemer S</co_aut></literature><literature><id>7451</id><title>Branched-chain &#945;-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes</title><author>Strauss KA,</author><journal>Mol Genet Metab</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7452</id><title>The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart r</title><author>Kaur J,</author><journal>Clin Chim Acta</journal><year>2020</year><book /><volume>500</volume><number>0</number><pages>195-201</pages><co_aut>et al.</co_aut></literature><literature><id>6993</id><title>Investigation of L - Carnitine Concentrations in Treated Patients with Maple Syrup Urine Disease</title><author>Kumru B,</author><journal>J Pediatr Genet</journal><year>2019</year><book /><volume>8</volume><number>3</number><pages>133-136</pages><co_aut>Oztuerk Hismi B</co_aut></literature><literature><id>6994</id><title>Identification of six novel mutations in five infants with suspected maple syrup urine disease based on blood and urine metabol</title><author>Yang C,</author><journal>Gene</journal><year>2019</year><book /><volume>710</volume><number>0</number><pages>9-16</pages><co_aut>et al.</co_aut></literature><literature><id>6995</id><title>Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, pros</title><author>Goyanes A,</author><journal>Int J Pharm</journal><year>2019</year><book /><volume>567</volume><number>0</number><pages>118497</pages><co_aut>et al.</co_aut></literature><literature><id>6996</id><title>Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations&lt;</title><author>Abiri M,</author><journal>Metab Brain Dis</journal><year>2019</year><book /><volume>34</volume><number>4</number><pages>1145-1156</pages><co_aut>et al.</co_aut></literature><literature><id>6997</id><title>[Progress of research on Maple syrup disease]</title><author>Yang C,</author><journal>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</journal><year>2019</year><book /><volume>36</volume><number>7</number><pages>737-741</pages><co_aut>et al.</co_aut></literature><literature><id>6998</id><title>Novel HILIC-ESI-MS method for urinary profiling of MSUD and methylmalonic aciduria biomarkers</title><author>Mathew EM,</author><journal>J Chromatogr Sci</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7453</id><title>Case report: maple syrup urine disease with a novel DBT gene mutation</title><author>Feng W,</author><journal>BMC Pediatr</journal><year>2019</year><book /><volume>19</volume><number>1</number><pages>484</pages><co_aut>et al.</co_aut></literature><literature><id>7454</id><title>Maple Syrup Urine Disease Decompensation Presenting as Papilloedema</title><author>Culleton S,</author><journal>Can J Neurol Sci</journal><year>2019</year><book /><volume>46</volume><number>6</number><pages>780-781</pages><co_aut>Siddiqui A</co_aut></literature><literature><id>6129</id><title>Two novel mutations in the BCKDHB gene that cause maple syrup urine disease</title><author>Han B,</author><journal>Pediatr Neonatol</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7455</id><title>Successful pregnancy in maple syrup urine disease: a case report and review of the literature</title><author>Gr&#252;nert SC,</author><journal>Nutr J</journal><year>2018</year><book /><volume>17</volume><number>1</number><pages>51</pages><co_aut>et al.</co_aut></literature><literature><id>4389</id><title>Two homozygous mutations in the exon 5 of BCKDHB gene that may cause the classic form of maple syrup urine disease.</title><author>Su L,</author><journal>Metab Brain Dis</journal><year>2017</year><book /><volume>32</volume><number>3</number><pages>765-772</pages><co_aut>et al.</co_aut></literature><literature><id>4390</id><title>Branched-Chain Amino Acids and Brain Metabolism</title><author>Sperringer JE,</author><journal>Neurochem Res</journal><year>2017</year><book /><volume>42</volume><number>6</number><pages>1697-1709</pages><co_aut>Addington A, Hutson SM</co_aut></literature><literature><id>5403</id><title>Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease</title><author>Abi-Warde MT,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6056</id><title>Maple syrup urine disease: mechanisms and management</title><author>Blackburn PR,</author><journal>Appl Clin Genet</journal><year>2017</year><book /><volume>10</volume><number>0</number><pages>57-66</pages><co_aut>et al.</co_aut></literature><literature><id>5679</id><title>Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment</title><author>Bravo-Alonso I,</author><journal>Data Brief</journal><year>2016</year><book /><volume>7</volume><number>0</number><pages>755-759</pages><co_aut>et al.</co_aut></literature><literature><id>5832</id><title>Isoleucine Deficiency in a Neonate Treated for Maple Syrup Urine Disease Masquerading as Acrodermatitis Enteropathica</title><author>Ross B,</author><journal>Indian Pediatr</journal><year>2016</year><book /><volume>53</volume><number>8</number><pages>738-740</pages><co_aut>et al.</co_aut></literature><literature><id>3499</id><title>The role of evidence analysts in creating nutrition management guidelines for inherited metabolic disorders</title><author>Osara Y,</author><journal>J Eval Clin Pract</journal><year>2015</year><book /><volume>21</volume><number>6</number><pages>1235-1243</pages><co_aut>et al.</co_aut></literature><literature><id>3504</id><title>Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease</title><author>Guo Y,</author><journal>Metab Brain Dis</journal><year>2015</year><book /><volume>30</volume><number>6</number><pages>1395-1400</pages><co_aut>Liming L, Jiang L</co_aut></literature><literature><id>3505</id><title>Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population:</title><author>Li X,</author><journal>Eur J Med Genet</journal><year>2015</year><book /><volume>58</volume><number>11</number><pages>617-623</pages><co_aut>et al.</co_aut></literature><literature><id>3506</id><title>Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation</title><author>Mescka CP,</author><journal>Metab Brain Dis</journal><year>2015</year><book /><volume>30</volume><number>5</number><pages>1167-1174</pages><co_aut>et al.</co_aut></literature><literature><id>3507</id><title>Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation</title><author>Wessel AE,</author><journal>JPEN J Parenter Enteral Nutr</journal><year>2015</year><book /><volume>39</volume><number>7</number><pages>875-879</pages><co_aut>et al.</co_aut></literature><literature><id>6128</id><title>Identification of mutations, genotype-phenotype correlation and prenatal diagnosis of maple syrup urine disease in Indian patie</title><author>Gupta D,</author><journal>Eur J Med Genet</journal><year>2015</year><book /><volume>58</volume><number>9</number><pages>471-478</pages><co_aut>et al.</co_aut></literature><literature><id>3500</id><title>Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach</title><author>Frazier DM,</author><journal>Mol Genet Metab</journal><year>2014</year><book /><volume>112</volume><number>3</number><pages>210-217</pages><co_aut>et al.</co_aut></literature><literature><id>3501</id><title>Neurological damage in MSUD: the role of oxidative stress</title><author>Sitta A,</author><journal>Cell Mol Neurobiol</journal><year>2014</year><book /><volume>34</volume><number>2</number><pages>157-165</pages><co_aut>et al.</co_aut></literature><literature><id>3502</id><title>The management of pregnancy in maple syrup urine disease: experience with two patients</title><author>Tchan M,</author><journal>JIMD Rep</journal><year>2013</year><book /><volume>10</volume><number>0</number><pages>113-117</pages><co_aut>et al.</co_aut></literature><literature><id>4667</id><title>Maple Syrup Urine Disease</title><author>Strauss KA,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2013</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3099</id><title>Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience</title><author>Mazariegos GV,</author><journal>J Pediatr</journal><year>2012</year><book /><volume>160</volume><number>1</number><pages>116-121</pages><co_aut>et al.</co_aut></literature><literature><id>3101</id><title>Young Adults with MSUD and Their Transition to Adulthood: Psychosocial Issues</title><author>Packman W,</author><journal>J Genet Couns</journal><year>2012</year><book /><volume>21</volume><number>5</number><pages>692-703</pages><co_aut>et al.</co_aut></literature><literature><id>3102</id><title>Analysis of gene mutations in Chinese patients with maple syrup urine disease</title><author>Yang N,</author><journal>Mol Genet Metab</journal><year>2012</year><book /><volume>106</volume><number>4</number><pages>412-418</pages><co_aut>et al.</co_aut></literature><literature><id>3104</id><title>Domino liver transplantation: how far can we push the paradigm?</title><author>Popescu I,</author><journal>Liver Transpl</journal><year>2012</year><book /><volume>18</volume><number>1</number><pages>22-28</pages><co_aut>Dima SO</co_aut></literature><literature><id>3503</id><title>Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy</title><author>Zinnanti WJ,</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>1</number><pages>71-79</pages><co_aut>Lazovic J</co_aut></literature><literature><id>3100</id><title>Disorders of amino acid metabolism associated with epilepsy</title><author>Lee WT</author><journal>Brain Dev</journal><year>2011</year><book /><volume>33</volume><number>9</number><pages>745-752</pages><co_aut /></literature><literature><id>3103</id><title>Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease</title><author>Zinnanti WJ,</author><journal>Brain</journal><year>2009</year><book /><volume>132</volume><number>0</number><pages>903-918</pages><co_aut>et al.</co_aut></literature><literature><id>5680</id><title>Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India</title><author>Bindu PS,</author><journal>J Child Neurol</journal><year>2007</year><book /><volume>22</volume><number>7</number><pages>911-913</pages><co_aut>et al.</co_aut></literature><literature><id>2611</id><title>Maple syrup urine disease: Favourable effect of early diagnosis by newborn screening on the neonatal course of the disease</title><author>Simon E</author><journal>J Inher Met Dis</journal><year>2006</year><book /><volume>29</volume><number>0</number><pages>532-537</pages><co_aut>et al.</co_aut></literature><literature><id>2372</id><title>Breastfeeding experience in inborn errors of metabolism other than phenylketonuria</title><author>Huner G</author><journal>J Inherit Metab Dis</journal><year>2005</year><book /><volume>28</volume><number>4</number><pages>457-465</pages><co_aut>et al.</co_aut></literature><literature><id>2489</id><title>Autistic spectrum disorder: atypical presentation of non-ketotic hyperglycinaemia and maple sirup urine disease?</title><author>Keng WT</author><journal>J Inher Met Dis Suppl 1 (SSIEM 42st Annual Symposium Paris)</journal><year>2005</year><book /><volume>28</volume><number>0</number><pages>52</pages><co_aut>et al.</co_aut></literature><literature><id>2642</id><title>Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake</title><author>Mitsubuchi H</author><journal>J Nutr Suppl</journal><year>2005</year><book /><volume>135</volume><number>0</number><pages>1565-70S</pages><co_aut>Owada M, Endo F</co_aut></literature><literature><id>2297</id><title>Diagnosis and treatment of maple syrup disease: a study of 36 patients</title><author>Morton DH</author><journal>Pediatrics</journal><year>2002</year><book /><volume>109</volume><number>6</number><pages>999-1008</pages><co_aut>et al.</co_aut></literature><literature><id>2296</id><title>Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation</title><author>Bodner-Leidecker A</author><journal>J Inherit Metab Dis</journal><year>2000</year><book /><volume>23</volume><number>8</number><pages>805-818</pages><co_aut>et al.</co_aut></literature><literature><id>2298</id><title>Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease</title><author>Schadewaldt P</author><journal>Clin Chem</journal><year>1999</year><book /><volume>45</volume><number>10</number><pages>1734-1740</pages><co_aut>et al.</co_aut></literature><literature><id>947</id><title>Pregnancy in a women with maple sirup urine disease</title><author>Gr&#252;newald S</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>2</number><pages>89-94</pages><co_aut>Hinrichs F, Wendel U</co_aut></literature><literature><id>99</id><title>Disorders of branched chain amino acid and keto acid metabolism</title><author>Chuang DT</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1239-1277</pages><co_aut>Shih VE</co_aut></literature><literature><id>228</id><title>Maple syrup urine disease 1954-1993</title><author>Peinemann F</author><journal>J Inherit Metab Dis</journal><year>1994</year><book /><volume>17</volume><number>0</number><pages>3-15</pages><co_aut>Danner DJ</co_aut></literature><literature><id>390</id><title>Pancreatitis in patients with organic acidemias</title><author>Kahler SG</author><journal>J Pediatr</journal><year>1994</year><book /><volume>124</volume><number>0</number><pages>239-243</pages><co_aut>et al.</co_aut></literature><literature><id>5907</id><title>On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in</title><author>Mamer OA,</author><journal>J Biol Chem</journal><year>1992</year><book /><volume>267</volume><number>31</number><pages>22141-147</pages><co_aut>Reimer ML</co_aut></literature><literature><id>687</id><title>Intellectual outcome in children with maple sirup urine disease</title><author>Kaplan P</author><journal>J Pediatr</journal><year>1991</year><book /><volume>119</volume><number>0</number><pages>46-50</pages><co_aut>et al.</co_aut></literature><literature><id>6052</id><title>Urinary D-4-hydroxyphenyllactate, D-phenyllactate and D-2-hydroxyisocaproate, abnormalities of bacterial origin</title><author>Spaapen LJ,</author><journal>J Inherit Metab Dis</journal><year>1987</year><book /><volume>10</volume><number>4</number><pages>383-390</pages><co_aut>et al.</co_aut></literature><literature><id>98</id><title>Disturbences of amino acid metabolism: clinical chemistry and diagnosis</title><author>Bremer HJ</author><journal>Urban und Schwarzenberg, Munich</journal><year>1981</year><book /><volume>0</volume><number>0</number><pages>359-361</pages><co_aut>Duram M, Kamerling JP, Przyrembel H, Wadman SK</co_aut></literature><literature><id>3193</id><title>Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases</title><author>Blau N</author><journal>Springer</journal><year>0</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature></Literatures></Disease>